About

Publications While At HealthPartners

selected publications

Journal Article

Liraglutide and cardiovascular outcomes in type 2 diabetes. 

New England Journal of Medicine. 2016

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. 

Diabetes, Obesity & Metabolism. 2015

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. 

Pancreas. 2014

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 

American Heart Journal. 2013

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. 

Lancet (London, England). 2010

Contact

full name

M. A. Nauck

Quick Info

 

Collaboration

Co-author network

Map of science